Background {#Sec1}
==========

Internationally, ethnic and indigenous inequalities in mortality within countries are increasingly recognized as a public health concern \[[@CR1]--[@CR4]\]. But few countries have data to monitor such inequalities accurately \[[@CR5]\]. We aimed to provide a detailed description of ethnic inequalities (Māori \[indigenous\] and Pacific compared to the benchmark, European/Other) in mortality for a country with high-quality ethnicity data, using both standard methods and novel visualization methods.

Ethnic inequalities in mortality in New Zealand are well-documented \[[@CR6]\]. Measurement of these inequalities matter, as they are markers of social (in)justice and (in)equity \[[@CR3]\]. Furthermore, understanding what causes these inequalities in the past, and how they are changing over time, with qualitative (at least) projections into the future, highlight where future mortality reduction gains could be made by ethnic group and inequalities reduced \[[@CR3]\].

There is some debate as to whether health inequality should be measured on relative or absolute scales \[[@CR7]\]. We demonstrate, however that, alongside the trend in the mortality rate, it may be optimal to consider both scales of inequality simultaneously, to provide a more holistic analysis of population mortality trends.

The indigenous New Zealand Māori population have had worse health than the European population since colonization during the 1800s. Whilst, life expectancy and mortality gaps have closed since c. 1900 \[[@CR8]\], with a notable period of widening again in the 1980s and 1990s \[[@CR6]\], in part driven by structural changes to liberalize the economy that impacted harder on Māori and probably also in part due to delayed phasing of the cardiovascular disease (CVD) epidemic for Māori compared to European/Other \[[@CR9]\], there was still a seven-year gap in life expectancy in 2011 \[[@CR10]\]. Reasons are numerous and intertwined: for example, the ongoing structure of domination and inequities associated with colonization \[[@CR11]\], which also plays a key structuring role in the ethnic patterning of risk factors (higher tobacco smoking rates for Māori, for example), and worse access to health services \[[@CR8]\], for example.

Pacific peoples began migrating to New Zealand in substantial numbers after World War II. Since reliable mortality data existed (from c. 1980 onwards), Pacific mortality has been intermediary between European/Other and Māori -- despite, on average, lower socioeconomic position of Pacific than Māori, and often healthier risk factor profiles (e.g., Pacific peoples (depending on country of origin) generally have lower smoking rates than Māori and often also European/Other \[[@CR12]\]).

Monitoring social group (whether this is ethnic group, gender group, or socioeconomic group) differences in health are important. For example, they inform us about the impacts of structural inequalities and drivers of health in society \[[@CR13]\]. The assembly and analysis of the best data available on mortality and ethnicity is one important way that we can deepen understanding of how health differences between social groups change over time and may be preventable.

Internationally, a major limitation of investigations into ethnic inequalities in health has been the quality of data on ethnicity \[[@CR14], [@CR15]\]. In particular, the use of surrogate indicators of ethnicity, such as country of birth or observer-assigned ethnicity, are often used instead of self-reported ethnicity on mortality data, which can lead to an mis-estimation (often underestimation) of mortality rates for indigenous groups \[[@CR5]\], when using census (or other population-wide count data) as a denominator.

Extensive efforts have been made in New Zealand to improve information on ethnicity in health datasets. However, issues remain with consistency and recording \[[@CR16]\]. These limitations are circumvented in this paper, through the use of the New Zealand Census Mortality Study (NZCMS). Information on people's self-identified ethnicity is collected through the Census. Census data is then linked to mortality records, at the individual level, creating repeated cohort studies of the entire population. Ethnicity from the Census file only is used for the calculation of mortality rates, thus avoiding numerator-denominator bias \[[@CR17]\].

In this study we build on our previous work by presenting a detailed analysis of both changing relative and absolute inequalities in mortality rates for both Māori and Pacific peoples (compared to the European/Other ethnic group), over the last 30 years. Specific objectives of the study were:To present trends in all-cause and cause-specific (CVD, lung cancer, non-lung cancer, respiratory disease, diabetes, unintentional injury and suicide) mortality by ethnic group.To present trends in mortality inequalities for Māori and Pacific each compared to European/Other, including using a new holistic graphical visualization tool.To comment on possible reasons for these inequalities and trends, and project what the future might hold.

Methods {#Sec2}
=======

Assembly of data {#Sec3}
----------------

We individually and probabilistically linked mortality and census records \[[@CR18]\]. Mortality records from 1981--1999 (the first four cohorts) for people who died within three years of the previous census night (1981, 1986, 1991, and 1996 respectively) were assembled and linked to the census. We limited our follow-up period to three years, in the first four cohorts due to concerns about diminishing record linkage. For the period 2001--2011 all mortality records were assembled, with little diminishing linkage rates as the follow-up period progressed. Direct age standardization, using the World Health Organization standard, was used to calculate rates, standardized rate differences (SRDs), and rate ratios (SRRs). All the data used in this report (and further disaggregations by mortality, age, and socioeconomic status are publicly available at the NZCMS Data Explorer \[[@CR19]\]).

Ethnicity, mortality.,and age variables {#Sec4}
---------------------------------------

The ethnic groups of interest were selected based on a consideration of statistical power and relevance to the main aim of monitoring ethnic inequalities in mortality. Information on ethnicity was taken from the Census file only. A total response ethnicity approach was used for Māori and Pacific peoples; the Total Asian group was omitted due to lack of statistical power when disaggregated by the mortalities of interest. Using "total response" means that there can be a slight overlap, where people self-identify as both Māori and Pacific \[[@CR20]\].

The remaining people (who did not identify as Māori, Pacific, or Asian) were assigned as European/Other; which, was set as the reference category. As mentioned previously, people of European background, on average, have had lower mortality rates since colonization, so setting this group as the benchmark population, makes conceptual sense.

The eight mortalities (including all-cause) with the highest standardized rates for the whole population, in the most recent (2006) cohort, was selected for analysis. Mortalities were coded using the International Classification of Disease (ICD-9 and ICD-10 in square brackets): all-cause, cardiovascular disease (393-438, 440-459 *\[I05-I15, I20-I99\]*), lung cancer (162 *\[C34\]*), non-lung cancer (140-161, 163-209 *\[C00-C32, C35-C97\]*), respiratory disease (470-478, 490-519 *\[J30-J39, J40-J47, J60-J70, J95-J99\]*), diabetes (250 *\[E10-E14\]*), unintentional injury (800-949 *\[V01-X59\]*), and suicide (950-959, 980-989 *\[X60-X84\]*).

We restricted our analysis to 1-74-year-olds. To be linked to a census record, individuals in the mortality data needed to be born prior to census night, i.e., it is a closed cohort. Accordingly, these cohorts are not well-positioned to examine infant mortality.

Annual percentage change, tests for linear trend, and contribution to absolute inequality {#Sec5}
-----------------------------------------------------------------------------------------

Poisson regression models were fitted on age-standardized mortality rates, for 1-74-year-olds across all cohorts, with the mid-date of each follow-up period specified as the independent variable. The estimated coefficient from the model fit was then transformed onto the linear scale, and converted into an annual percentage change in mortality. These values are displayed in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. We have also calculated p-values testing whether there are linear trends in rates differences, and the log of standardized rates and rate ratios. However, not all of the trends we present exhibit a linear pattern across all six cohorts, but still do change significantly. We therefore also refer to significant non-linear changes between cohorts for given causes of death, if the 95% confidence intervals between the two cohorts of interest do not overlap.Table 11--74-year-old male all-cause and cause-specific standardized mortality rates (per 100,000), standardized rate differences (per 100,000), standardized rate ratios, annual percentage change, and p for linear trend statisticsMalesTotal MāoriTotal PacificEuropean/OtherFollow-up periodMortalityStandardized rate (per 100,000)Standardized rate difference (per 100,000)Standardized rate ratioPacificStandardized rate differenceStandardized rate ratioStandardized rate (per 100,000)1981--1984All-cause1005 (944 - 1066)443.1 (381.1 - 505.1)1.79 (1.68 - 1.91)671 (561 - 780)108.7 (-1.1 - 218.6)1.19 (1.01 - 1.41)562 (553 - 571)1986--1989922 (869 - 975)405.8 (352.1 - 459.6)1.79 (1.68 - 1.90)784 (690 - 878)267.3 (172.9 - 361.6)1.52 (1.34 - 1.71)516 (508 - 525)1991--1994960 (908 - 1011)513.8 (461.7 - 565.8)2.15 (2.03 - 2.28)630 (556 - 703)183.9 (110.3 - 257.5)1.41 (1.26 - 1.59)446 (438 - 454)1996--1999898 (858 - 937)521.3 (481.3 - 561.2)2.39 (2.27 - 2.50)679 (620 - 738)302.4 (243.3 - 361.5)1.80 (1.65 - 1.97)376 (369 - 383)2001--2006806 (778 - 835)467.1 (438.0 - 496.3)2.38 (2.29 - 2.47)598 (559 - 638)259.3 (219.4 - 299.2)1.76 (1.65 - 1.89)339 (334 - 344)2006--2011701 (676 - 725)424.3 (399.4 - 449.2)2.53 (2.44 - 2.63)495 (461 - 528)218.1 (184.6 - 251.5)1.79 (1.67 - 1.92)276 (272 - 281)Change p.a. (%)-1.21-1.19-2.65P Trend\<0.010.6\<0.010.020.830.04\<0.011981--1984CVD461 (419 - 503)197.2 (154.5 - 239.8)1.75 (1.59 - 1.92)265 (198 - 333)1.7 (-65.7 - 69.1)1.01 (0.78 - 1.30)264 (258 - 270)1986--1989390 (353 - 426)164.8 (127.9 - 201.6)1.73 (1.57 - 1.91)329 (266 - 392)104.6 (41.4 - 167.8)1.47 (1.21 - 1.78)225 (219 - 230)1991--1994409 (374 - 443)234.4 (199.7 - 269.2)2.34 (2.15 - 2.56)268 (222 - 313)93.2 (47.4 - 138.9)1.53 (1.29 - 1.82)174 (170 - 179)1996--1999348 (323 - 373)219.8 (194.5 - 245.1)2.72 (2.52 - 2.94)262 (226 - 298)134.0 (97.4 - 170.5)2.05 (1.78 - 2.36)128 (124 - 132)2001--2006288 (271 - 306)187.7 (170.2 - 205.3)2.86 (2.68 - 3.06)223 (198 - 247)122.0 (97.4 - 146.6)2.21 (1.98 - 2.48)101 (98 - 104)2006--2011240 (225 - 254)168.9 (154.1 - 183.7)3.38 (3.16 - 3.62)170 (151 - 190)99.3 (79.7 - 119.0)2.40 (2.13 - 2.71)71 (69 - 73)Change p.a. (%)-2.27-1.75-4.85P Trend\<0.010.28\<0.010.010.53\<0.01\<0.011981--1984Lung cancer88 (69 - 107)43.4 (24.4 - 62.4)1.98 (1.58 - 2.47)24 (6 - 41)-21.0 (-39.1 - -2.9)0.53 (0.25 - 1.14)45 (42 - 47)1986--198986 (69 - 103)46.6 (29.4 - 63.8)2.17 (1.77 - 2.67)45 (21 - 68)4.8 (-18.7 - 28.2)1.12 (0.66 - 1.90)40 (37 - 42)1991--1994100 (82 - 117)65.6 (48.2 - 83.1)2.94 (2.44 - 3.53)44 (23 - 64)9.6 (-11.4 - 30.6)1.28 (0.79 - 2.08)34 (32 - 36)1996--199994 (81 - 107)66.3 (53.2 - 79.4)3.36 (2.89 - 3.91)64 (44 - 83)35.5 (15.9 - 55.1)2.26 (1.66 - 3.10)28 (26 - 30)2001--200677 (68 - 86)49.3 (40.1 - 58.6)2.79 (2.45 - 3.17)39 (28 - 50)11.4 (0.5 - 22.2)1.41 (1.07 - 1.87)28 (26 - 29)2006--201171 (63 - 79)50.7 (42.6 - 58.8)3.47 (3.06 - 3.94)50 (39 - 61)29.4 (17.9 - 40.9)2.43 (1.92 - 3.08)21 (19 - 22)Change p.a. (%)-0.741.64-2.77P Trend0.070.870.070.30.070.13\<0.011981--1984Non-lung cancer132 (110 - 154)29.1 (7.1 - 51.1)1.28 (1.08 - 1.52)150 (96 - 204)47.0 (-7.1 - 101.2)1.46 (1.01 - 2.09)103 (99 - 107)1986--1989134 (114 - 153)29.6 (9.7 - 49.6)1.29 (1.11 - 1.49)141 (102 - 181)37.6 (-2.5 - 77.7)1.36 (1.02 - 1.81)104 (100 - 108)1991--1994149 (129 - 169)42.4 (22.5 - 62.3)1.40 (1.22 - 1.60)110 (80 - 141)3.7 (-27.3 - 34.8)1.04 (0.78 - 1.37)107 (103 - 110)1996--1999146 (130 - 162)45.2 (29.3 - 61.2)1.45 (1.30 - 1.62)135 (108 - 161)33.7 (6.8 - 60.6)1.33 (1.09 - 1.63)101 (97 - 104)2001--2006164 (151 - 177)61.4 (48.0 - 74.8)1.60 (1.47 - 1.74)125 (106 - 143)21.8 (3.1 - 40.5)1.21 (1.04 - 1.41)103 (100 - 106)2006--2011143 (132 - 154)51.3 (40.0 - 62.7)1.56 (1.44 - 1.69)99 (84 - 113)6.8 (-7.9 - 21.5)1.07 (0.92 - 1.25)92 (89 - 94)Change p.a. (%)0.57-1.22-0.35P Trend0.360.040.010.080.160.120.111981--1984Respiratory disease82 (65 - 99)47.1 (30.2 - 64.1)2.36 (1.90 - 2.93)63 (15 - 112)28.7 (-19.9 - 77.2)1.83 (0.85 - 3.95)35 (32 - 37)1986--198962 (47 - 77)33.9 (19.1 - 48.8)2.21 (1.72 - 2.83)87 (50 - 123)58.6 (21.9 - 95.3)3.09 (2.01 - 4.74)28 (26 - 30)1991--199452 (38 - 66)31.0 (17.0 - 44.9)2.45 (1.86 - 3.23)54 (27 - 82)33.1 (5.2 - 61.0)2.55 (1.52 - 4.29)21 (20 - 23)1996--199950 (40 - 61)29.6 (19.3 - 40.0)2.43 (1.96 - 3.02)38 (23 - 53)17.1 (1.9 - 32.4)1.83 (1.22 - 2.75)21 (19 - 22)2001--200651 (43 - 58)32.3 (24.3 - 40.4)2.78 (2.35 - 3.29)31 (21 - 42)13.1 (2.7 - 23.4)1.72 (1.23 - 2.41)18 (17 - 19)2006--201144 (38 - 51)31.2 (24.7 - 37.7)3.38 (2.87 - 3.98)30 (20 - 40)17.0 (7.1 - 26.8)2.29 (1.64 - 3.21)13 (12 - 14)Change p.a. (%)-2.14-3.83-3.34P Trend0.020.210.020.040.180.36\<0.011981--1984Diabetes32 (20 - 44)24.5 (12.6 - 36.5)4.49 (2.99 - 6.75)33 (6 - 60)25.8 (-1.5 - 53.0)4.67 (2.01 - 10.86)7 (6 - 8)1986--198944 (32 - 56)38.2 (26.5 - 49.8)7.65 (5.63 - 10.39)31 (10 - 52)25.1 (4.3 - 45.9)5.37 (2.69 - 10.72)6 (5 - 7)1991--199455 (42 - 69)50.4 (37.1 - 63.7)11.34 (8.50 - 15.13)23 (9 - 36)17.6 (4.1 - 31.1)4.61 (2.48 - 8.56)5 (4 - 6)1996--199962 (52 - 73)56.1 (45.4 - 66.7)10.07 (8.10 - 12.52)39 (25 - 53)32.5 (18.3 - 46.6)6.25 (4.23 - 9.23)6 (5 - 7)2001--200667 (58 - 75)59.8 (51.3 - 68.3)9.59 (8.13 - 11.31)59 (46 - 71)51.5 (39.2 - 63.9)8.40 (6.63 - 10.64)7 (6 - 8)2006--201156 (49 - 62)49.9 (43.0 - 56.9)9.93 (8.40 - 11.74)48 (37 - 59)42.2 (31.4 - 53.0)8.55 (6.64 - 10.99)6 (5 - 6)Change p.a. (%)2.062.63-0.16P Trend0.110.10.270.080.070.0111981--1984Unintentional injury95 (79 - 110)46.1 (30.1 - 62.0)1.95 (1.63 - 2.33)62 (39 - 86)14.0 (-9.9 - 37.9)1.29 (0.88 - 1.89)48 (45 - 51)1986--198982 (71 - 94)33.6 (21.8 - 45.4)1.69 (1.46 - 1.97)56 (38 - 74)7.8 (-10.3 - 25.9)1.16 (0.84 - 1.60)48 (46 - 51)1991--199478 (66 - 89)37.9 (26.0 - 49.7)1.95 (1.65 - 2.29)36 (23 - 48)-4.2 (-16.9 - 8.6)0.90 (0.63 - 1.28)40 (37 - 43)1996--199972 (62 - 82)41.7 (31.3 - 52.0)2.37 (2.02 - 2.79)39 (28 - 50)8.8 (-2.4 - 20.1)1.29 (0.96 - 1.73)30 (28 - 33)2001--200654 (48 - 60)26.1 (19.7 - 32.5)1.94 (1.70 - 2.21)35 (27 - 43)7.1 (-0.7 - 15.0)1.26 (1.00 - 1.58)28 (26 - 30)2006--201153 (47 - 58)26.7 (20.5 - 32.9)2.03 (1.78 - 2.32)22 (16 - 28)-3.4 (-9.6 - 2.8)0.87 (0.66 - 1.14)26 (24 - 28)Change p.a. (%)-2.32-3.48-2.83P Trend\<0.010.060.490.010.30.53\<0.011981--1984Suicide14 (8 - 19)-3.2 (-8.8 - 2.4)0.81 (0.54 - 1.22)13 (4 - 23)-3.6 (-13.3 - 6.1)0.78 (0.38 - 1.64)17 (15 - 19)1986--198917 (12 - 23)-6.0 (-12.0 - 0.0)0.74 (0.53 - 1.04)18 (9 - 27)-5.3 (-14.8 - 4.3)0.77 (0.46 - 1.30)23 (21 - 26)1991--199423 (17 - 28)-2.0 (-8.2 - 4.1)0.92 (0.70 - 1.20)18 (9 - 26)-6.9 (-15.9 - 2.1)0.72 (0.43 - 1.19)25 (22 - 27)1996--199940 (32 - 47)13.5 (5.4 - 21.7)1.52 (1.23 - 1.89)20 (12 - 28)-6.2 (-14.4 - 2.0)0.76 (0.51 - 1.15)26 (24 - 28)2001--200628 (24 - 32)8.2 (3.6 - 12.7)1.41 (1.19 - 1.68)19 (14 - 25)-0.3 (-5.9 - 5.3)0.99 (0.74 - 1.32)20 (18 - 21)2006--201127 (23 - 31)8.3 (3.9 - 12.7)1.45 (1.22 - 1.73)17 (12 - 21)-1.8 (-6.5 - 3.0)0.90 (0.68 - 1.20)18 (17 - 20)Change p.a. (%)2.520.63-0.07P Trend0.10.030.050.660.160.120.8 Table 21--74-year-old female all-cause and cause-specific standardized mortality rates (per 100,000), standardized rate differences (per 100,000) and standardized rate ratiosFemalesTotal MāoriTotal PacificEuropean/OtherFollow-up periodMortalityStandardized rate (per 100,000)Standardized rate difference (per 100,000)Standardized rate ratioStandardized rate (per 100,000)Standardized rate difference (per 100,000)Standardized rate ratioStandardized rate (per 100,000)1981--1984All-cause692 (642 - 742)389.5 (339.0 - 440.0)2.29 (2.12 - 2.47)389 (315 - 462)86.6 (12.7 - 160.4)1.29 (1.06 - 1.56)302 (296 - 309)1986--1989626 (585 - 668)347.3 (305.5 - 389.1)2.25 (2.09 - 2.41)425 (359 - 491)146.0 (79.4 - 212.7)1.52 (1.30 - 1.78)279 (273 - 285)1991--1994612 (575 - 649)365.4 (328.1 - 402.7)2.48 (2.33 - 2.65)386 (336 - 436)139.7 (89.6 - 189.8)1.57 (1.37 - 1.79)246 (241 - 252)1996--1999597 (566 - 629)382.4 (350.8 - 414.0)2.78 (2.63 - 2.94)393 (352 - 434)178.1 (136.9 - 219.3)1.83 (1.64 - 2.03)215 (210 - 220)2001--2006571 (548 - 593)363.7 (341.0 - 386.4)2.76 (2.64 - 2.88)356 (328 - 383)148.7 (120.9 - 176.5)1.72 (1.59 - 1.86)207 (203 - 211)2006--2011475 (457 - 494)300.7 (282.1 - 319.4)2.72 (2.61 - 2.84)348 (324 - 372)173.0 (148.8 - 197.1)1.99 (1.85 - 2.14)175 (171 - 178)Change p.a. (%)-1.16-0.59-2.04P Trend0.010.110.030.020.130.02\<0.011981--1984CVD304 (270 - 338)185.4 (151.2 - 219.7)2.57 (2.28 - 2.88)158 (112 - 203)39.2 (-6.9 - 85.2)1.33 (0.99 - 1.78)118 (114 - 122)1986--1989258 (231 - 285)162.3 (134.7 - 190.0)2.70 (2.41 - 3.02)167 (121 - 213)70.9 (24.8 - 117.0)1.74 (1.32 - 2.30)96 (92 - 99)1991--1994228 (204 - 252)154.5 (130.5 - 178.6)3.10 (2.77 - 3.47)149 (116 - 181)74.9 (42.3 - 107.5)2.02 (1.62 - 2.52)74 (71 - 76)1996--1999201 (182 - 219)148.7 (129.9 - 167.5)3.87 (3.49 - 4.29)129 (106 - 152)77.3 (53.8 - 100.7)2.49 (2.07 - 3.00)52 (50 - 54)2001--2006169 (157 - 182)124.7 (111.9 - 137.4)3.79 (3.49 - 4.13)109 (93 - 125)64.1 (48.1 - 80.0)2.43 (2.09 - 2.83)45 (43 - 46)2006--2011124 (115 - 134)93.8 (83.9 - 103.8)4.07 (3.71 - 4.46)91 (78 - 103)60.2 (47.7 - 72.8)2.97 (2.57 - 3.43)31 (29 - 32)Change p.a. (%)-3.06-2.18-5.02P Trend\<0.01\<0.01\<0.01\<0.010.64\<0.01\<0.011981--1984Lung cancer56 (41 - 70)43.7 (29.0 - 58.3)4.62 (3.49 - 6.12)12 (11 - 13)1986--198955 (43 - 67)40.7 (28.7 - 52.8)3.93 (3.09 - 4.99)19 (4 - 34)5.1 (-9.6 - 19.9)1.37 (0.63 - 2.97)14 (13 - 15)1991--199458 (47 - 69)43.0 (31.9 - 54.0)3.78 (3.08 - 4.65)12 (4 - 21)-3.1 (-11.8 - 5.7)0.80 (0.40 - 1.62)15 (14 - 17)1996--199969 (58 - 80)53.2 (42.1 - 64.2)4.35 (3.64 - 5.20)21 (11 - 32)5.5 (-5.1 - 16.0)1.34 (0.82 - 2.21)16 (15 - 17)2001--200674 (66 - 82)57.0 (48.6 - 65.3)4.31 (3.80 - 4.90)26 (18 - 33)8.6 (0.9 - 16.3)1.50 (1.11 - 2.03)17 (16 - 18)2006--201165 (58 - 71)48.5 (41.8 - 55.2)4.01 (3.56 - 4.52)20 (15 - 26)4.3 (-1.5 - 10.0)1.26 (0.95 - 1.68)16 (15 - 17)Change p.a. (%)1.021.51.2P Trend0.170.240.790.040.060.420.021981--1984Non-lung cancer127 (107 - 147)28.5 (8.6 - 48.5)1.29 (1.10 - 1.51)95 (59 - 130)-3.8 (-39.7 - 32.0)0.96 (0.66 - 1.40)99 (95 - 102)1986--1989122 (105 - 139)25.6 (8.3 - 42.9)1.27 (1.10 - 1.46)105 (72 - 138)8.4 (-24.9 - 41.6)1.09 (0.79 - 1.49)97 (93 - 100)1991--1994123 (107 - 138)29.1 (13.3 - 44.8)1.31 (1.15 - 1.49)90 (67 - 113)-4.0 (-27.1 - 19.2)0.96 (0.74 - 1.24)94 (90 - 97)1996--1999139 (125 - 153)49.8 (35.0 - 64.6)1.56 (1.40 - 1.74)115 (92 - 138)26.2 (3.0 - 49.3)1.29 (1.06 - 1.58)89 (86 - 92)2001--2006139 (128 - 150)53.7 (42.8 - 64.6)1.63 (1.50 - 1.77)100 (86 - 114)14.6 (0.2 - 29.1)1.17 (1.01 - 1.36)85 (83 - 88)2006--2011137 (128 - 147)60.8 (50.9 - 70.8)1.80 (1.66 - 1.94)114 (101 - 128)37.9 (24.3 - 51.6)1.50 (1.33 - 1.69)77 (74 - 79)Change p.a. (%)0.490.6-0.9P Trend0.06\<0.01\<0.010.220.050.04\<0.011981--1984Respiratory disease62 (47 - 76)47.7 (33.3 - 62.1)4.43 (3.44 - 5.70)21 (6 - 36)7.0 (-8.1 - 22.2)1.50 (0.73 - 3.12)14 (13 - 15)1986--198967 (53 - 82)51.6 (37.0 - 66.1)4.31 (3.41 - 5.45)34 (18 - 49)18.0 (2.8 - 33.2)2.16 (1.36 - 3.42)16 (14 - 17)1991--199457 (45 - 69)43.3 (31.2 - 55.4)4.12 (3.28 - 5.17)25 (12 - 38)11.1 (-2.5 - 24.6)1.80 (1.04 - 3.10)14 (13 - 15)1996--199952 (43 - 62)38.7 (29.0 - 48.4)3.82 (3.12 - 4.68)15 (8 - 23)1.5 (-6.3 - 9.4)1.11 (0.66 - 1.86)14 (13 - 15)2001--200658 (51 - 66)43.8 (36.3 - 51.4)4.01 (3.47 - 4.64)19 (13 - 25)4.4 (-1.8 - 10.6)1.31 (0.94 - 1.81)15 (14 - 16)2006--201151 (44 - 57)38.3 (31.9 - 44.8)4.16 (3.59 - 4.81)20 (14 - 26)7.5 (1.6 - 13.5)1.62 (1.19 - 2.20)12 (11 - 13)Change p.a. (%)-0.81-1.4-0.32P Trend0.10.090.370.460.660.40.171981--1984Diabetes34 (21 - 46)29.2 (16.8 - 41.7)7.84 (5.17 - 11.89)33 (7 - 59)28.8 (3.0 - 54.7)7.75 (3.47 - 17.32)4 (4 - 5)1986--198934 (23 - 44)29.2 (18.8 - 39.6)7.70 (5.40 - 10.98)24 (9 - 39)19.7 (4.4 - 34.9)5.52 (2.86 - 10.65)4 (4 - 5)1991--199449 (38 - 60)45.3 (34.5 - 56.0)13.43 (10.11 - 17.85)25 (11 - 38)20.9 (7.4 - 34.4)6.74 (3.78 - 12.02)4 (3 - 4)1996--199947 (38 - 57)44.1 (34.7 - 53.6)15.98 (12.15 - 21.01)45 (31 - 59)42.3 (28.2 - 56.5)15.36 (10.68 - 22.10)3 (2 - 4)2001--200645 (38 - 51)40.9 (34.4 - 47.3)12.29 (10.07 - 15.01)43 (33 - 52)38.9 (29.3 - 48.4)11.74 (9.01 - 15.30)4 (3 - 4)2006--201128 (24 - 33)25.4 (20.9 - 29.9)9.61 (7.75 - 11.91)40 (32 - 49)37.2 (28.5 - 45.9)13.62 (10.50 - 17.66)3 (3 - 3)Change p.a. (%)0.061.75-2.52P Trend0.410.470.880.110.10.180.071981--1984Unintentional injury25 (18 - 31)8.1 (1.7 - 14.5)1.49 (1.14 - 1.96)15 (2 - 27)-1.8 (-14.7 - 11.1)0.89 (0.37 - 2.16)16 (15 - 18)1986--198927 (20 - 33)11.1 (4.4 - 17.7)1.71 (1.31 - 2.22)16 (9 - 24)0.6 (-7.2 - 8.3)1.04 (0.64 - 1.67)16 (14 - 17)1991--199428 (21 - 34)14.8 (8.2 - 21.3)2.14 (1.66 - 2.77)14 (7 - 21)1.0 (-6.0 - 8.0)1.08 (0.65 - 1.78)13 (12 - 14)1996--199921 (17 - 26)11.1 (6.3 - 15.9)2.11 (1.64 - 2.72)10 (5 - 16)0.2 (-5.3 - 5.7)1.02 (0.59 - 1.75)10 (9 - 11)2001--200622 (18 - 26)12.9 (9.1 - 16.8)2.44 (2.00 - 2.98)7 (4 - 10)-2.3 (-5.6 - 1.1)0.75 (0.46 - 1.22)9 (8 - 10)2006--201118 (15 - 21)8.6 (5.6 - 11.6)1.94 (1.60 - 2.34)9 (6 - 13)0.1 (-3.6 - 3.7)1.01 (0.68 - 1.50)9 (8 - 10)Change p.a. (%)-1.36-2.83-2.54P Trend0.030.670.210.090.680.590.011981--1984Suicide3 (1 - 5)-3.5 (-6.0 - -1.0)0.45 (0.20 - 1.01)6 (5 - 8)1986--19894 (2 - 6)-2.5 (-4.8 - -0.1)0.63 (0.38 - 1.06)7 (6 - 8)1991--19944 (2 - 7)-2.2 (-4.7 - 0.3)0.66 (0.38 - 1.16)3 (0 - 6)-3.2 (-6.3 - -0.2)0.50 (0.20 - 1.24)6 (5 - 8)1996--199910 (7 - 14)3.9 (0.6 - 7.1)1.59 (1.13 - 2.23)6 (2 - 10)-0.6 (-4.3 - 3.2)0.91 (0.49 - 1.70)7 (6 - 8)2001--20068 (6 - 10)1.7 (-0.4 - 3.9)1.26 (0.97 - 1.65)4 (2 - 6)-3.0 (-5.2 - -0.7)0.55 (0.31 - 0.99)7 (6 - 7)2006--20119 (7 - 11)3.8 (1.7 - 5.9)1.71 (1.32 - 2.20)4 (2 - 6)-1.1 (-3.1 - 0.8)0.79 (0.50 - 1.24)5 (5 - 6)Change p.a. (%)4.89-0.17-0.47P Trend0.020.010.040.20.090.380.16

To calculate the contribution of a given cause of mortality to absolute inequalities in overall mortality, we divided each mortality specific SRD by the all-cause mortality SRD.

Inequality classification and typology graphs {#Sec6}
---------------------------------------------

When assessing changing inequalities in mortality between groups in society, it is desirable to report on both the relative and absolute scales simultaneously, whilst assessing the underlying mortality rates for each respective group. The rate of the ethnic group of interest, SRR and SRD are mathematically interrelated -- if one knows the Māori rate and rate ratio, for example, one can calculate the rate difference through simple formula rearrangement. This means that all of the standardized rates, SRR, and SRD for a given mortality can be displayed on the same plot, with the trends over time of the three respective measures summarized by one line.

As such, we applied a visualization technique similar to Blakely et al.'s \[[@CR21]\] socioeconomic plots (see Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). The log of the rate for either Māori or Pacific peoples are plotted on the x-axis, the log of the SRR (European/Other as reference) on the y-axis, and contour plots for SRDs (again with European/Other as reference). This allows simultaneous assessment of the trends in all of relative and absolute inequality and the ethnic-specific mortality rate for either Māori or Pacific peoples.

All six cohorts were plotted for all-cause mortality and CVD respectively. For the remaining six causes of mortality (non-lung cancer, lung cancer, respiratory, diabetes, suicide, and unintentional injury), the rates in the 1980s, 1990s, and 2000s are averaged to gain statistical stability.

To further aid classification of trends in both mortality rates, SRDs, and SRRs, for each given mortality, the Blakely et al. typology is used to compare Māori and Pacific to European/Other. Each mortality is assigned a label (see Table [3](#Tab3){ref-type="table"}) to denote whether Māori/Pacific mortality rates (denoted by '*m'*), absolute inequalities (denoted by '*a'*) and relative inequalities (denoted by *'r'*) are declining (*↓*), stable (-), or increasing (*↑*). As trends change over time and statistical power varies, where there is a significant p-value on the test for linear trend the appropriate component (*'m,' 'a,'* or *'r'*) of the inequality typology is underlined.Table 3Inequality classification for each disease-specific standardized mortality rate (per 100,000), standardized rate difference (per 100,000) and standardized rate ratio for Māori and Pacific peoples, 1-74-year-olds, males and femalesMāoriPacificDisease groupMaleFemaleMaleFemaleAll-cause***[m↓]{.ul}*** *a↓* ***[r↑]{.ul}**[m↓]{.ul}*** *a↓* ***[r↓]{.ul}**[m↓]{.ul}*** *a↓* ***[r-]{.ul}**[m↓]{.ul}*** *a↓* ***[r↑]{.ul}**[m↓]{.ul}*** *a↑* ***[r↑]{.ul}***CVD***[m↓]{.ul}*** *a↓* ***[r↑]{.ul}**[m↓ a↓ r↑]{.ul}**[m↓ a↓ r-]{.ul}**[m↓]{.ul}*** *a↓* ***[r↑]{.ul}**[m↓]{.ul}*** *a↑* ***[r↑]{.ul}***Lung cancer*m↑ a↑ r↑m↓ a↓ r-m↑ a↑ r-m↑ a↑ r↑m- a- r-*Non-lung cancers*m↑* ***[a↑ r↑]{.ul}****m↑* ***[a↑ r↑]{.ul}****m↓ a↓ r↓m↑ a↑ r↑*Respiratory disease***[m↓]{.ul}*** *a↓* ***[r↑]{.ul}****m↓ a↓ r-****[m↓]{.ul}*** *a↓ r↓****[m↓]{.ul}*** *a↓ r-*Diabetes*m↑ a↑ r↑m- a- r↑m↑ a↑* ***[r↑]{.ul}****m↑ a↑* ***[r↑]{.ul}***Unintentional injury***[m↓]{.ul}*** *a↓ r-****[m↓]{.ul}*** *a- r↑****[m↓]{.ul}*** *a↓ r-****[m↓]{.ul}*** *a- r-*Suicide*m↑ a↑ r↑m↓ a↓ r-****[m↑ a↑ r↑]{.ul}****m- a- r-m- a- r-*Typologies are assigned according to underlying trends in mortality rates, taking the study period as a whole. Where the trend on the typology plot clearly changes over time, two typologies are assigned to a given mortality. A bold underlined component of the typology indicates that particular trend was found to be significant at the 95% level (*p* \< 0.05)

The least desirable pattern, from a health perspective, is that of increasing mortality rates, increasing absolute (SRD) and relative inequalities (SRR), which would be labeled as '*m↑ a↑ r↑'.* In terms of a trend line on the typology plots (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}), a compass analogy is used to allow interpretation across an array of trend line directions. An increasing mortality rate would appear as a shift to the east (right) on the horizontal (x-axis). Where relative inequalities have increased, there is a shift north (upwards) with respect to the vertical axis (y-axis), and an increase in absolute inequalities results in a shift across the SRD contour lines in mainly northeast (right and up) direction.

Results {#Sec7}
=======

All-cause mortality {#Sec8}
-------------------

For each ethnic group there was a fall in all-cause mortality rates over the study period. Before analyzing any changes in inequality, we first considered the annual percentage change in all-cause mortality over the study period, for each ethnic group. For males, the annual percentage change for European/Other was -2.65%; whereas, for Māori it was -1.21% and for Pacific peoples it was -1.19%, with all three test for linear trends being statistically significant (Table [1](#Tab1){ref-type="table"}). For females there is a similar ranking -- European/Other falling most quickly (-2.04%) followed by Māori (-1.16%), with the Pacific female rate only falling by -0.59%.

For Māori males, there was no statistically significant change in rates over the first three follow-up periods (1981--1984 to 1991--1994); whereas, in the final four follow-up periods (1991--1994 to 2006--2011) there was a significant downward trend in mortality from 960 (per 100,000) to 701 (per 100,000). Pacific males showed an overall similar pattern to Māori in all-cause rates -- a period of no significant reduction in mortality followed by a downward trend, in this case the final three follow-up periods (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Trends in *male* 1--74 year old all-cause and cause-specific standardized mortality rates (per 100,000), absolute standardized rate differences (per 100,000) and rate ratios for Māori and Pacific compared to European/Other. Shaded area around trends line denotes 95% confidence interval. Data available at: <https://nzcms-ct-data-explorer.shinyapps.io/version8/>

Absolute inequalities in all-cause mortality for Māori males (European/Other) showed a statistically significant reduction in SRDs in the three most recent cohorts, from 521 (per 100,000) in 1996--1999 to 424 (per 100,000) in 2006--2011 (Table [1](#Tab1){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"}). In contrast, relative inequalities in all-cause mortality for Māori compared to European/Other increased from 1.79 in 1981--1984 to 2.53 in 2006--2011.

Figure [3](#Fig3){ref-type="fig"} shows the holistic inequality plot for Māori and Pacific males, providing a summary of the trends in SMRs, SRDs, and SRRs simultaneously, with the arrowhead denoting the most recent cohort of data. For Māori males, rates in all-cause mortality (red line) have decreased shifting to the west (left) on the x-axis; relative inequalities have increased (a shift northwards with respect to the y-axis); and there has been little change to absolute inequalities (with little/no movement across the dotted contour lines). The trend was similar for Pacific males and the pattern for both ethnic groups was a '*m↓ a↓ r↑'* typology.

Figure [4](#Fig4){ref-type="fig"} shows the inequality typology plot for females. With a consistent decline in the female European/Other mortality rate (Fig. [2](#Fig2){ref-type="fig"}), the slower decline evident in the middle cohorts for Māori (flatter trend line in Fig. [2](#Fig2){ref-type="fig"} and less of a westerly movement on Fig. [4](#Fig4){ref-type="fig"}) resulted in a slight increase in absolute inequality between 1986--1989 (347 per 100,000) and 1996--1999 (382 per 100,000). There was then a fall to 301 (per 100,000) in 2006--2011 represented in a movement towards the 320 SRD contour on Fig. [4](#Fig4){ref-type="fig"}.Fig. 2Trends in *female* 1--74 year old all-cause and cause-specific standardized mortality rates (per 100,000), absolute standardized rate differences (per 100,000) and rate ratios for Māori, Pacific and European/Other ethnic groups. Shaded area around trends line denotes 95% confidence interval. Data available at: <https://nzcms-ct-data-explorer.shinyapps.io/version8/>

The SRR for Māori females is higher at the end of the study period (2.72) than at the beginning (2.29), with no significant change in the three most recent cohorts. In recent cohorts, the trends described above have resulted in the typology line bending round in a westerly direction crossing the 320 SRD contour line (reducing Māori mortality rate, falling absolute inequality, and a slight fall in relative inequalities) -- a marginal '*m↓ a↓ r↓'* or '*m↓ a↓ r-'*typology.

For Pacific females, the lower annual percentage change reduction in all-cause mortality than European/Other and Māori is reflected in an increase in the SRDs over the study period, from 87 to 173 (per 100,000). Relative inequalities also increase from 1.29 (1981--1984) to 1.99 (2006--2011). This is reflected in a general northerly movement on the inequality typology plot (Fig. [4](#Fig4){ref-type="fig"}). The line, having moved completely across the gap between the 80 SRD and 160 SRD contours (an increase in absolute inequality), only moves slightly westwards (a slow fall in the Pacific all-cause rate) and shifts north (indicating increasing relative inequalities). There is some noise evident in the trend, due to smaller numbers; however, the more general trend across cohorts suggests a '*m↓ a↑ r↑'* typology.

Major diseases contributing to the trends in inequalities {#Sec9}
---------------------------------------------------------

### General transition {#Sec10}

CVD still remains the largest specific disease contributor to absolute inequalities in all-cause mortality by ethnicity (highest SRDs are for CVD; arrow head for most recent cohort on holistic inequality plots for CVD positioned more north(east) than other mortalities of interest). However, there is a transition evident: away from CVD and towards cancer as the emerging important contributor to absolute inequalities.

### Contribution of CVD {#Sec11}

Overall, there was a decline in CVD rates for both males and females (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). For males, the annual percentage change over the entire 30 years for European/Other (-4.81%) exhibits a faster rate of decline than both Māori (-2.23%) and Pacific (-1.71%). This ethnic-specific pattern is also evident for females: European/Other -4.98%; Māori -3.05%; Pacific -2.15%.

In terms of the disease-specific contribution to all-cause absolute inequalities, CVD has remained the main contributor. For Māori males, the SRD accounts for 39% of the all-cause absolute inequality. Its contribution was higher in earlier cohorts, for example 44% in 1991--1994 and 43% in 1981--1984. However, absolute inequality is falling in the three most recent cohorts. Considering relative inequality, absolute inequality, and the male Māori mortality rate concurrently, there is a bend towards a north-west direction (mortality rate falling, SRD beginning to fall, and SRR consistently increasing) -- a '*m↓ a↓ r↑'* classification.

For male Pacific peoples, the CVD SRD contributed 45% of the all-cause absolute inequality. Over the first four cohorts, there was a northerly trend on the inequality typology (Fig. [3](#Fig3){ref-type="fig"}) -- increases in absolute and relative inequalities and little to no change in the mortality rate. In the two most recent cohorts, though, this trend has bent round to a north-westerly direction as a result of a falling mortality rate, falling absolute inequalities and slower increases in relative inequality (classified as '*m↓ a↓ r↑').* Fig. 3Graphical presentation of Māori and Pacific inequalities and mortality rates for males, 1--74-year-olds 1981--2011 (with SRDs (contour lines) and SRRs (log scale y-axis) compared to European/Other)

For female Māori, there have been a statistically significant fall in absolute inequalities for CVD. With this reduction in absolute inequalities, the importance of CVD, in terms of its contribution to all-cause absolute inequalities, has declined. In 2006--2011 it contributed 31% of the absolute gap in all-cause mortality between Māori and European/Other; down from 47% in 1981--1984. In the three most recent cohorts there has been a marked reduction in the SRD and a plateauing of the SRR -- the line on the inequality typology plot has consequently turned westward, -- on the borderline between a '*m↓ a↓ r↑'* and '*m↓ a↓ r-'*classification.

Even though the Pacific SRD for CVD was consistently lower than Māori, absolute inequalities have increased. The SRDs in more recent cohorts suggest that absolute inequalities have plateaued, however. The contribution of CVD, to absolute inequalities, has recently declined -- peaking at 53% in 1991--1994 and falling to 35% in 2006--2011.

### Cancer patterns -- particularly for females {#Sec12}

Cancer has become a more important contributor to absolute inequalities for Māori, especially for females. For example, the mortality rate for Māori females has a much later peak, during 2001--2006, than for Māori males, during 1991--1994 (Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}).

In particular, absolute and relative inequalities for lung cancer in Māori females are large and greater than for Pacific. The contribution of lung cancer to all-cause absolute inequality for Māori females is 16% and less than 1% for Pacific. There is a similar pattern for males.

Considering both inequality measures and the standardized mortality rate concurrently, there is an eastward movement for the lung cancer typology line, from the 1980s to 2000s, for Māori females (Fig. [4](#Fig4){ref-type="fig"}), resulting in a summary '*m↑ a↑ r-'* typology across the whole study period.Fig. 4Graphical presentation of Māori and Pacific inequalities and mortality rates for females, 1--74 years olds 1981--2011 (with SRDs (contour lines) and SRRs (log scale y-axis) compared to European/Other)

For both Māori and Pacific females, non-lung cancer rates have been increasing. The trends in inequality are similar to lung cancer (Fig. [4](#Fig4){ref-type="fig"}) -- a general north-east direction and '*m↑ a↑ r↑'* classification. In recent cohorts, females of both ethnic groups have a higher mortality rate for non-lung cancer than CVD, but with lower relative and absolute inequalities.

### Other selected drivers of inequalities {#Sec13}

There has been a fall in absolute inequalities in unintentional injury for Māori males, from 45 (per 100,000) to 26 (per 100,000), alongside a falling mortality rate (annual percentage change of -2.28%). The inequality typology plots for unintentional injury exhibit a general westward movement and typology classification of '*m↓ a↓ r-'.* But for suicide in Māori, there have been large increasing absolute and relative inequalities, reflected in a general northern movement in the typology plot (Fig. [3](#Fig3){ref-type="fig"}).

Diabetes clearly has the highest level of relative inequalities for both Māori and Pacific (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). There was a significant increase in relative inequalities for each ethnic group by sex combination, and there has been a worsening of both relative and absolute inequalities since the beginning of the study period. Pacific peoples' inequalities from diabetes have been marginally worse than for Māori (moving northeast on Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}).

Discussion {#Sec14}
==========

Main findings {#Sec15}
-------------

The decline in all-cause mortality rates for all ethnic groups in New Zealand is a favourable finding from a public health perspective. Even so, for males during the 1980s and 1990s there was actually a slight increase and stagnation in this pattern for Māori and Pacific. This development, largely driven by CVD, contributed to an increase in absolute inequalities, which are now falling in the three most recent cohorts.

Another main finding is the continuation of substantial relative and absolute inequalities in mortality for both Māori and Pacific in relation to European/Other. Pacific all-cause mortality has been falling at a slower rate than both Māori and European/Other across the whole study period, and particularly for females. This has resulted in increasing absolute inequalities for Pacific females while the opposite has been the case for Māori females across the whole study period.

All-cause relative inequalities are still high and increasing for Māori males and Pacific females. However, for Pacific males and Māori females, there are signs that relative inequality, whilst still high, has not been getting worse.

In terms of the main contributors to inequalities, there appears to be a transition, particularly amongst females, away from CVD and towards cancer, especially non-lung cancer. The steady decline in female European/Other non-lung cancer mortality rates compared to a steady rise in both Māori and Pacific has resulted in rises of both absolute and relative inequality. Furthermore, whilst there are examples of falling absolute inequalities (mainly respiratory disease and unintentional injury) relative inequalities are, on the whole, large (especially diabetes) and increasing.

The human cost associated with these inequalities is striking. Fortunately, many of the diseases driving this inequality can be addressed -- as we detail further below.

Strengths and limitations of this study {#Sec16}
---------------------------------------

The linking of individual census data to mortality records enabled us to analyze 30 years' worth of mortality trends for the population of an entire country. Having six follow-up periods has now allowed us to have a greater detailed understanding of how trends in both the rate and inequalities are changing over time.

Furthermore, common deficiencies in ethnicity data have been circumvented by using the self-defined ethnicity variable from the Census, and numerator-denominator bias is avoided. The study size is also very large -- with 68.9 million years of person time follow-up. However, there are still specific diseases (e.g., for female Pacific peoples for lung cancer and suicide for 1981--1984) where small numbers limited statistical power. Small numbers also limited the extent to which we could consider mortality-specific trends disaggregated by ethnicity and age. Where numbers permitted (for example, all-cause mortality), we found that trends in ethnic-specific standardized mortality rates are similar by age. Furthermore, there were people of a non-European ethnic background included in the European/Other group (i.e., people who do not self-identify as Māori, Pacific, Asian or European). However, these numbers are likely to be small and not have a significant effect on our findings. Future research could assess the sensitivity of our findings to this and build on previous work \[[@CR12]\] to identify whether there is heterogeneity in mortality trends within ethnic groups.

Potential implications for reducing ethnic inequalities {#Sec17}
-------------------------------------------------------

The ethnic inequalities in mortality identified in this paper are so striking that, we argue, a consideration of how they can be reduced has to start with a critical assessment of how society is structured. Macroeconomic and social policy are one such structuring factor. Previous research for New Zealand has indicated that the widening in ethnic inequalities in 1980s and 1990s was contributed to by structural economic changes to liberalize the market economy \[[@CR9]\].

Indeed, further risks for widening inequalities may persist if automation and other globalization forces result in increased unemployment and insecure employment among lower-skilled workers \[[@CR22]\]. Nevertheless, there can be progress, as seen with more rapid increases in the percentage of Māori and Pacific school leavers with school qualifications \[[@CR23]\]. However, faster progress is required if there is to be a significant erosion of the entrenched inequalities in health we identified. Measures such as additional education support, improvements in social housing provision, tax reform (e.g., re-introducing estate (inheritance) taxes, and reducing income taxes for low-income families) and a living wage should all be seriously considered.

Another structural driver of inequalities in mortality is the obesogenic environment \[[@CR24]\]. In New Zealand, as with many other high-income countries, a high body mass index is now the largest single cause of health loss \[[@CR25]\]. This is also likely to be a driver for inequalities from CVD, diabetes, and some types of cancer for both Māori and Pacific peoples (given much higher burdens of overweight and obesity \[[@CR26]\]).

Detailed analysis of both cancer incidence and mortality by Teng et al. \[[@CR27]\] has found that ethnic inequalities have actually widened most in the incidence of obesity-related cancers in New Zealand (breast and endometrial cancer in particular). While the New Zealand government has recently adopted an obesity control strategy, there is still scope for more substantive interventions to address obesogenic environments, e.g., Mexican-style taxes on sugary drinks \[[@CR28]\], banning junk food marketing to children, and mandatory front of package health rating labeling of food. If such measures were well-designed, and appropriately implemented, they should contribute to reductions in inequalities (e.g., there is some evidence for greater response by lower socioeconomic groups in Mexico to reduced consumption of sugary drink tax after the new tax \[[@CR28]\]).

The second most important cause of health loss in New Zealand is from smoking \[[@CR25]\]. Furthermore, our results for ethnic inequalities in lung cancer (and to some extent for CVD, and other cancers) are likely to reflect the marked ethnic gradient in tobacco smoking in New Zealand; both currently and as projected into the future \[[@CR29]\]. This highlights the potential for further advances in tobacco control; and, indeed the New Zealand government has a smoke-free nation goal for the year 2025.

Recent interventions include annual tobacco tax increases in the years 2010 to 2016, banning point-of-sales displays of tobacco, and a plan to finalize a law requiring the plain packaging for tobacco products. But interventions that may disproportionately benefit Māori may include tax increases (as per New Zealand modeling work \[[@CR30]\]) and mass media campaigns designed for a Māori audience \[[@CR31], [@CR32]\]. More profound interventions to accelerate progress to the tobacco endgame have also been discussed for New Zealand and elsewhere: a sinking lid on sales \[[@CR33]\], tobacco retail outlet reduction \[[@CR34]\], and a smoke-free generation (i.e., no one born after the year 2000 is allowed to purchase tobacco \[[@CR35]\]). The New Zealand public appear to be broadly supportive of such endgame strategies \[[@CR36]\] and these are consistent with international calls to reduce the overall burden and inequalities from the global tobacco epidemic \[[@CR37]\].

A further domain for inequality reduction interventions is in accelerating the ongoing declines in CVD risk. Modeling work for New Zealand has suggested that multiple population-wide dietary sodium reduction measures are likely to provide greater per capita health gain for Māori relative to non-Māori \[[@CR38]\]. Health services also matter and there remain some gaps in terms of the provision of CVD risk screening in primary care for Māori vs. non-Māori (at 86% vs. 92% coverage respectively) \[[@CR39]\]. However the target age-range for such screening for Māori starts at a young age (to assist with equity goals) and there have been successful campaigns to increase preventive CVD pharmacotherapy among Māori (e.g., for statin use \[[@CR40]\]).

Finally, another area for health service improvements are addressing the inequalities, or inequities, in receipt of some cancer treatments between ethnic groups in New Zealand \[[@CR41]\] and ethnic/racial groups internationally \[[@CR42]\]. Some of these inequalities are challenging to address: e.g., higher comorbidities among ethnic groups, which may be perceived as limiting treatment options. But gains are likely to be possible, and will contribute somewhat to reducing (or at least slowing) ethnic inequalities in mortality. Improvements in diabetes care may also be a likely fertile area for policies and actions to reduce ethnic inequalities in mortality.

Conclusions {#Sec18}
===========

In conclusion, for this case study (New Zealand), we found a favorable decline in all-cause mortality rates over time by ethnic group. Large ethnic mortality inequalities are generally stable (or even falling) in absolute terms, but have increased on a relative scale. The cause of death drivers of inequalities are changing over time, away from CVD to cancer and diabetes. To further decrease (absolute, in particular) inequalities, there is still more to gain from CVD mortality reductions, but increasingly acting on the causes and treatments of cancer and diabetes will be required. Cancer and obesity-related illnesses are likely to remain major contributors to health loss and drivers of New Zealand's stark ethnic inequalities in mortality. To address these inequalities, policymakers need to enhance prevention activities and improve health care delivery with a clear equity focus, and also support wider improvements in educational achievement and socioeconomic position for Māori and Pacific peoples.

CVD

:   Cardiovascular disease

ICD

:   International classification of disease

NZCMS

:   New Zealand Census Mortality Study

SRD

:   Standardized rate difference

SRR

:   Standardized rate ratio
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